54709-94-3 Usage
General Description
5-Methyl-3(2H)-pyridazinone is a chemical compound with the molecular formula C5H6N2O. It is a heterocyclic compound that consists of a pyridazine ring with a methyl group and a ketone functional group attached to it. 5-Methyl-3(2H)-pyridazinone is used in the synthesis of pharmaceuticals and other organic compounds. It has potential applications in the development of drugs for various medical conditions. The compound may also be used as a starting material or intermediate in the production of other chemicals. Additionally, it has been studied for its potential pharmacological properties and its role in biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 54709-94-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,7,0 and 9 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 54709-94:
(7*5)+(6*4)+(5*7)+(4*0)+(3*9)+(2*9)+(1*4)=143
143 % 10 = 3
So 54709-94-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N2O/c1-4-2-5(8)7-6-3-4/h2-3H,1H3,(H,7,8)
54709-94-3Relevant articles and documents
Synthesis of substituted pyridines and pyridazines via ring closing metathesis
Donohoe, Timothy J.,Fishlock, Lisa P.,Basutto, Jose A.,Bower, John F.,Procopiou, Panayiotis A.,Thompson, Amber L.
supporting information; experimental part, p. 3008 - 3010 (2009/12/01)
RCM can be used to make aromatic heterocycles, namely pyridines and, for the first time, pyridazines; the key step after RCM involves elimination of sulfinate to provide the aromatic system. The Royal Society of Chemistry 2009.
AMINO 1,2,4-TRIAZOLE DERIVATIVES AS MODULATORS OF MGLUR5
-
Page/Page column 23-24, (2009/05/29)
The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
THIOPHENE 1,2,4-TRIAZOLE DERIVATIVES AS MODULATORS OF MGLUR5
-
Page/Page column 19, (2009/05/29)
The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
